+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Eubiotics Market Size, Share & Industry Trends Analysis Report By Product, By Application, By Form, By End-use, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 97 Pages
  • May 2022
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5615874
The Asia Pacific Eubiotics Market is expected to witness market growth of 8.6% CAGR during the forecast period (2022-2028).

A calf's digestive tract evolves and converts from milk to grain in the first few weeks of life.  At the same time, the growing immune system is relying on passive immunity from mom as it makes the shift to active immunity. In the case of sick calves, antibiotics can be helpful. Antibiotics are being used more prudently today to prevent and treat calf illness. Eubiotics can be a great part of a good calf health program, and sustaining normal, healthy calves is essential to good calf health.

Eubiotics can be administered as a feed, a liquid, a drench, a bolus, a gel, or a paste. A powder containing eubiotics can be put into milk for young, growing calves, providing an uncomplicated delivery system that requires no additional labor. A tube-based gel or paste is another alternative for calves to get eubiotics whenever and wherever they want. The delivery method is vital, but sticking to a feeding schedule is much more important." A calf's developing digestive tract gets the nourishment it requires throughout the first few weeks of life with a consistent, daily feed routine.

The Government of India's Ministry of Agriculture maintains four Central Poultry Development Organizations. The Central Poultry Breeding Farm Chandigarh and the Regional Feed Analytical Laboratory, Chandigarh were amalgamated after the Government of India restructured its poultry units, and the organization was renamed Central Poultry Development Organization (Northern area) Chandigarh. The organization will act as a single point of contact for the technical needs of poultry farmers in India's northern area, as well as work to promote the poultry industry in India.

Department of Animal Husbandry & Dairying announces 20th Livestock Census; livestock population climbs 4.6 percent over Census-2012, to 535.78 million, according to the Press Information Bureau. Moreover, as per the Integrated Sample Survey, India's average annual cattle productivity in 2019-20 is 1777 kg per animal per year, compared to the average of 2699 kg per animal per year in 2019.

The China market dominated the Asia Pacific Eubiotics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $551.1 million by 2028. The Japan market is anticipated to grow at a CAGR of 7.9% during (2022 - 2028). Additionally, The India market is expected to showcase a CAGR of 9.3% during (2022 - 2028).

Based on Product, the market is segmented into Probiotics, Organic Acids, Phytogenic, Prebiotics, and Enzymes. Based on Application, the market is segmented into Gut Health, Immunity, Yield, and Others. Based on Form, the market is segmented into Solid and Liquid. Based on End-use, the market is segmented into Poultry Feed, Swine Feed, Cattle Feed, Aquatic Feed, and Others. Based on countries, the market is segmented into China, Japan, India, Australia, South Korea, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., Novozymes A/S, BASF SE, DuPont de Nemours, Inc., Chr. Hansen holding A/S, Lallemand, Inc., Lesaffre Group, Kemin Industries, Inc., Cargill Corporation, and Calpis Co., Ltd.

By Product

  • Probiotics
  • Organic Acids
  • Phytogenic
  • Prebiotics
  • Enzymes

By Application

  • Gut Health
  • Immunity
  • Yield
  • Others

By Form

  • Solid
  • Liquid

By End-use

  • Poultry Feed
  • Swine Feed
  • Cattle Feed
  • Aquatic Feed
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific

Key Market Players


List of Companies Profiled in the Report:

  • Koninklijke DSM N.V.
  • Novozymes A/S
  • BASF SE
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Lallemand, Inc.
  • Lesaffre Group
  • Kemin Industries, Inc.
  • Cargill Corporation
  • Calpis Co., Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Eubiotics Market, by Product
1.4.2 Asia Pacific Eubiotics Market, by Application
1.4.3 Asia Pacific Eubiotics Market, by Form
1.4.4 Asia Pacific Eubiotics Market, by End-use
1.4.5 Asia Pacific Eubiotics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Eubiotics Market
Chapter 4. Asia Pacific Eubiotics Market by Product
4.1 Asia Pacific Probiotics Market by Country
4.2 Asia Pacific Organic Acids Market by Country
4.3 Asia Pacific Phytogenic Market by Country
4.4 Asia Pacific Prebiotics Market by Country
4.5 Asia Pacific Enzymes Market by Country
Chapter 5. Asia Pacific Eubiotics Market by Application
5.1 Asia Pacific Gut Health Market by Country
5.2 Asia Pacific Immunity Market by Country
5.3 Asia Pacific Yield Market by Country
5.4 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Eubiotics Market by Form
6.1 Asia Pacific Solid Market by Country
6.2 Asia Pacific Liquid Market by Country
Chapter 7. Asia Pacific Eubiotics Market by End-use
7.1 Asia Pacific Poultry Feed Market by Country
7.2 Asia Pacific Swine Feed Market by Country
7.3 Asia Pacific Cattle Feed Market by Country
7.4 Asia Pacific Aquatic Feed Market by Country
7.5 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Eubiotics Market by Country
8.1 China Eubiotics Market
8.1.1 China Eubiotics Market by Product
8.1.2 China Eubiotics Market by Application
8.1.3 China Eubiotics Market by Form
8.1.4 China Eubiotics Market by End-use
8.2 Japan Eubiotics Market
8.2.1 Japan Eubiotics Market by Product
8.2.2 Japan Eubiotics Market by Application
8.2.3 Japan Eubiotics Market by Form
8.2.4 Japan Eubiotics Market by End-use
8.3 India Eubiotics Market
8.3.1 India Eubiotics Market by Product
8.3.2 India Eubiotics Market by Application
8.3.3 India Eubiotics Market by Form
8.3.4 India Eubiotics Market by End-use
8.4 Australia Eubiotics Market
8.4.1 Australia Eubiotics Market by Product
8.4.2 Australia Eubiotics Market by Application
8.4.3 Australia Eubiotics Market by Form
8.4.4 Australia Eubiotics Market by End-use
8.5 South Korea Eubiotics Market
8.5.1 South Korea Eubiotics Market by Product
8.5.2 South Korea Eubiotics Market by Application
8.5.3 South Korea Eubiotics Market by Form
8.5.4 South Korea Eubiotics Market by End-use
8.6 Malaysia Eubiotics Market
8.6.1 Malaysia Eubiotics Market by Product
8.6.2 Malaysia Eubiotics Market by Application
8.6.3 Malaysia Eubiotics Market by Form
8.6.4 Malaysia Eubiotics Market by End-use
8.7 Rest of Asia Pacific Eubiotics Market
8.7.1 Rest of Asia Pacific Eubiotics Market by Product
8.7.2 Rest of Asia Pacific Eubiotics Market by Application
8.7.3 Rest of Asia Pacific Eubiotics Market by Form
8.7.4 Rest of Asia Pacific Eubiotics Market by End-use
Chapter 9. Company Profiles
9.1 Koninklijke DSM N.V.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisitions and Mergers:
9.1.5.3 Product Launches and Product Expansions:
9.2 Novozymes A/S
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 BASF SE
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 DuPont de Nemours, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Chr. Hansen Holding A/S
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Lallemand, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.7 Lesaffre Group
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Partnerships, Collaborations, and Agreements:
9.8 Kemin Industries, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.9 Cargill Corporation
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.10. Calpis Co., Ltd. (Asahi Group Holdings, Ltd.)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental Analysis
9.10.4 Recent strategies and developments:
9.10.4.1 Approvals and Trials:

Companies Mentioned

  • Koninklijke DSM N.V.
  • Novozymes A/S
  • BASF SE
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Lallemand, Inc.
  • Lesaffre Group
  • Kemin Industries, Inc.
  • Cargill Corporation
  • Calpis Co., Ltd.

Methodology

Loading
LOADING...